Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Resonant Group is a UK-based healthcare communications collective that provides strategic, creative, and medical communication services to the global pharmaceutical and biotechnology sectors. The group is comprised of specialized agencies, most notably Bedrock Healthcare Communications and Origins Patient Insights, which focus on medical affairs and patient-centric research respectively. In June 2022, the company was acquired by Fishawack Health, which subsequently rebranded as Avalere Health in 2023. Resonant Group is recognized for its 'freethinking' philosophy, aiming to bridge the gap between complex scientific data and meaningful health outcomes for patients and clinicians. Their service portfolio includes medical education, strategic brand development, and deep-dive patient experience mapping. The organization supports a wide range of therapeutic areas, working with many of the world's leading life science companies to drive engagement and product awareness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Resonant Group.